IN Brief:
- CME plans European futures and options for skimmed milk powder, butter, whey powder and liquid milk, subject to regulatory review.
- The proposed contracts would be financially settled, initially using EEX indices before a transition to CME indices.
- September open-interest records concern CME’s existing dairy derivatives business, not trading in the proposed European contracts.
CME Group has specified four proposed European dairy futures and options products, covering skimmed milk powder, butter, whey powder and liquid milk. Announced on 19 October, the contracts are intended to launch before the end of 2026, subject to regulatory review. They would be financially settled under CME rules. The exchange has not announced that the new European contracts are already trading, nor has it published evidence of trading volumes for products that remain at the proposal stage.
The announcement gives individual product categories and a near-term launch objective to the wider dairy market transition agreed with the European Energy Exchange (EEX) on 8 September. Under that earlier arrangement, EEX intends to phase out its dairy derivatives business while supporting a transfer of relevant indices and activity to CME. EEX said its existing futures would remain available for their listed maturities. Neither that agreement nor the new product plan should be read as confirmation that the transition has already been completed.
The four underlying product categories represent different exposures along the dairy supply chain. Liquid milk prices affect the raw material purchased by processors, while butter, skimmed milk powder and whey powder can be major outputs or inputs depending on the factory. The commercial risk facing a milk powder manufacturer therefore differs from that of a bakery buying butter or a formulated-food producer using whey ingredients. Prices are also shaped by distinct supply conditions, composition specifications and regional demand, so a single dairy price rarely captures every operation’s exposure.
Cash settlement means that contracts still open at expiry are settled through a financial payment linked to a reference index, rather than delivery of milk, butter or powder. A manufacturer exposed to rising ingredient prices may take a long position in an appropriate futures contract, while a processor selling dairy commodities may take a short position to offset some exposure to falling prices. Either hedge can diverge from the factory’s physical invoices because product specifications, local supply conditions and negotiated premiums do not necessarily change with the index.
CME intends initially to settle the new contracts against EEX price indices and subsequently to use CME Group indices. Index selection determines which reported commodity prices are reflected in cash settlement. The reference may capture movements in a broad European market without mirroring an individual factory’s contracted grade, delivery terms or freight bill. If the benchmark changes during a longer hedging programme, users will need to compare the two methodologies and assess whether the new reference still tracks their physical exposure.
CME reported average open interest of 420,922 contracts per day across its existing dairy complex in September, up 42% year on year, and a single-day record of 461,493 on 29 September. Open interest measures outstanding positions, not the number of trades in a newly introduced market. Both reported totals belong to CME’s established dairy business and cannot be used as a measure of demand for its planned European contracts. The degree of liquidity available to European processors will only become measurable after launch.
European milk processing commonly divides raw milk into multiple product streams, including cream, butter, skimmed milk powder and whey-related products, with equipment and capacity determining which outputs a site can produce. Changes in the relative value of these streams can influence production scheduling and product mix. A financially settled contract cannot remove physical constraints such as energy costs, drying capacity, storage life or milk quality, but it can provide a separate instrument for managing some price exposure over a chosen period.
The proposed CME products will also have to be distinguished from Euronext’s separate European dairy contracts, for which butter and skimmed milk powder trading began on 19 October. Euronext’s instruments use Vesper reference prices rather than the EEX-to-CME index sequence described by CME. Two contracts based on similarly named dairy products need not provide the same hedge when the index, maturity, clearing arrangements or market liquidity differs. No interoperability between the two exchanges’ products has been announced.
CME and EEX are also working on transferring the EEX Weekly European Cheese Indices and the Pan European Butter Index for continued industry use. That undertaking concerns indices, not an announced European cheese futures contract from CME. Product specifications, listed contract months, position limits and practical market access arrangements will determine the eventual trading choices. Until the exchange publishes the approved terms, food companies cannot calculate an exact hedge ratio from the names of the four proposed products alone.
Derivative hedging introduces its own management obligations. A factory or ingredient supplier must establish its physical exposure, choose a suitable contract size and expiry, monitor differences between its actual prices and the settlement index, and fund any margin requirements while a position remains open. A favourable longer-term hedge may still require short-term cash when futures prices move against it. Systems for treasury control and clear reporting therefore remain as necessary as knowledge of processing costs.
The next operational milestones are regulatory clearance and publication of final exchange specifications, followed by actual trading. At that point processors and ingredient suppliers can test whether the indices, maturities and liquidity are suitable for their physical exposures. CME’s 19 October announcement establishes four proposed product categories and their intended settlement approach; it does not itself change raw-milk prices, processing costs or the availability of financial hedges already traded elsewhere. The earlier EEX transition remains a separate, longer programme.



